P3.07-004 Nivolumab for Non-Small Cell Lung Cancer (NSCLC): An Economic Model for Risk Sharing Based on Real-Life Data
- Resource Type
- Source
- Journal of Thoracic Oncology. 12:S1432-S1433
- Subject
Pulmonary and Respiratory Medicine Oncology medicine.medical_specialty business.industry non-small cell lung cancer (NSCLC) medicine.disease Real life data Internal medicine Risk sharing medicine Economic model Nivolumab business - Language
- ISSN
- 1556-0864